List of Tables
Table 1. Amino Acid Metabolism Disorder Drug Market Trends
Table 2. Amino Acid Metabolism Disorder Drug Market Drivers & Opportunity
Table 3. Amino Acid Metabolism Disorder Drug Market Challenges
Table 4. Amino Acid Metabolism Disorder Drug Market Restraints
Table 5. Global Amino Acid Metabolism Disorder Drug Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Amino Acid Metabolism Disorder Drug Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Amino Acid Metabolism Disorder Drug Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Amino Acid Metabolism Disorder Drug Product Type
Table 9. Key Companies Time to Begin Mass Production of Amino Acid Metabolism Disorder Drug
Table 10. Global Amino Acid Metabolism Disorder Drug Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amino Acid Metabolism Disorder Drug as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Amino Acid Metabolism Disorder Drug Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Amino Acid Metabolism Disorder Drug Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Amino Acid Metabolism Disorder Drug Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Amino Acid Metabolism Disorder Drug Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Amino Acid Metabolism Disorder Drug Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Amino Acid Metabolism Disorder Drug Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Amino Acid Metabolism Disorder Drug Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Amino Acid Metabolism Disorder Drug Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Amino Acid Metabolism Disorder Drug Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Amino Acid Metabolism Disorder Drug Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Amino Acid Metabolism Disorder Drug Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Amino Acid Metabolism Disorder Drug Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Amino Acid Metabolism Disorder Drug Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Amino Acid Metabolism Disorder Drug Sales Value by Region (2019-2024) & (%)
Table 27. Global Amino Acid Metabolism Disorder Drug Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Amino Acid Metabolism Disorder Drug Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Amino Acid Metabolism Disorder Drug Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Amino Acid Metabolism Disorder Drug Sales Value, (2025-2030) & (US$ Million)
Table 31. GlaxoSmithKline Basic Information List
Table 32. GlaxoSmithKline Description and Business Overview
Table 33. GlaxoSmithKline Amino Acid Metabolism Disorder Drug Products, Services and Solutions
Table 34. Revenue (US$ Million) in Amino Acid Metabolism Disorder Drug Business of GlaxoSmithKline (2019-2024)
Table 35. GlaxoSmithKline Recent Developments
Table 36. Pfizer Basic Information List
Table 37. Pfizer Description and Business Overview
Table 38. Pfizer Amino Acid Metabolism Disorder Drug Products, Services and Solutions
Table 39. Revenue (US$ Million) in Amino Acid Metabolism Disorder Drug Business of Pfizer (2019-2024)
Table 40. Pfizer Recent Developments
Table 41. AMINO Basic Information List
Table 42. AMINO Description and Business Overview
Table 43. AMINO Amino Acid Metabolism Disorder Drug Products, Services and Solutions
Table 44. Revenue (US$ Million) in Amino Acid Metabolism Disorder Drug Business of AMINO (2019-2024)
Table 45. AMINO Recent Developments
Table 46. Merck Basic Information List
Table 47. Merck Description and Business Overview
Table 48. Merck Amino Acid Metabolism Disorder Drug Products, Services and Solutions
Table 49. Revenue (US$ Million) in Amino Acid Metabolism Disorder Drug Business of Merck (2019-2024)
Table 50. Merck Recent Developments
Table 51. Recordati Basic Information List
Table 52. Recordati Description and Business Overview
Table 53. Recordati Amino Acid Metabolism Disorder Drug Products, Services and Solutions
Table 54. Revenue (US$ Million) in Amino Acid Metabolism Disorder Drug Business of Recordati (2019-2024)
Table 55. Recordati Recent Developments
Table 56. DSM Basic Information List
Table 57. DSM Description and Business Overview
Table 58. DSM Amino Acid Metabolism Disorder Drug Products, Services and Solutions
Table 59. Revenue (US$ Million) in Amino Acid Metabolism Disorder Drug Business of DSM (2019-2024)
Table 60. DSM Recent Developments
Table 61. Sanofi Basic Information List
Table 62. Sanofi Description and Business Overview
Table 63. Sanofi Amino Acid Metabolism Disorder Drug Products, Services and Solutions
Table 64. Revenue (US$ Million) in Amino Acid Metabolism Disorder Drug Business of Sanofi (2019-2024)
Table 65. Sanofi Recent Developments
Table 66. Kyowa Hakko Kirin Basic Information List
Table 67. Kyowa Hakko Kirin Description and Business Overview
Table 68. Kyowa Hakko Kirin Amino Acid Metabolism Disorder Drug Products, Services and Solutions
Table 69. Revenue (US$ Million) in Amino Acid Metabolism Disorder Drug Business of Kyowa Hakko Kirin (2019-2024)
Table 70. Kyowa Hakko Kirin Recent Developments
Table 71. BioMarin Basic Information List
Table 72. BioMarin Description and Business Overview
Table 73. BioMarin Amino Acid Metabolism Disorder Drug Products, Services and Solutions
Table 74. Revenue (US$ Million) in Amino Acid Metabolism Disorder Drug Business of BioMarin (2019-2024)
Table 75. BioMarin Recent Developments
Table 76. Swedish Orphan Biovitrum Basic Information List
Table 77. Swedish Orphan Biovitrum Description and Business Overview
Table 78. Swedish Orphan Biovitrum Amino Acid Metabolism Disorder Drug Products, Services and Solutions
Table 79. Revenue (US$ Million) in Amino Acid Metabolism Disorder Drug Business of Swedish Orphan Biovitrum (2019-2024)
Table 80. Swedish Orphan Biovitrum Recent Developments
Table 81. Shine Star (Hubei) Biological Engineering Basic Information List
Table 82. Shine Star (Hubei) Biological Engineering Description and Business Overview
Table 83. Shine Star (Hubei) Biological Engineering Amino Acid Metabolism Disorder Drug Products, Services and Solutions
Table 84. Revenue (US$ Million) in Amino Acid Metabolism Disorder Drug Business of Shine Star (Hubei) Biological Engineering (2019-2024)
Table 85. Shine Star (Hubei) Biological Engineering Recent Developments
Table 86. Key Raw Materials Lists
Table 87. Raw Materials Key Suppliers Lists
Table 88. Amino Acid Metabolism Disorder Drug Downstream Customers
Table 89. Amino Acid Metabolism Disorder Drug Distributors List
Table 90. Research Programs/Design for This Report
Table 91. Key Data Information from Secondary Sources
Table 92. Key Data Information from Primary Sources
Table 93. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Amino Acid Metabolism Disorder Drug Product Picture
Figure 2. Global Amino Acid Metabolism Disorder Drug Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Amino Acid Metabolism Disorder Drug Sales Value (2019-2030) & (US$ Million)
Figure 4. Amino Acid Metabolism Disorder Drug Report Years Considered
Figure 5. Global Amino Acid Metabolism Disorder Drug Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Amino Acid Metabolism Disorder Drug Revenue in 2023
Figure 7. Amino Acid Metabolism Disorder Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Arginine Picture
Figure 9. Folic Acid Picture
Figure 10. Vitamin B6 & B12 Picture
Figure 11. Thiamine Picture
Figure 12. Vitamin D Picture
Figure 13. Betaine Picture
Figure 14. Carglumic Acid Picture
Figure 15. Sapropterin Dihydrochloride Picture
Figure 16. Others Picture
Figure 17. Global Amino Acid Metabolism Disorder Drug Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global Amino Acid Metabolism Disorder Drug Sales Value Market Share by Type, 2023 & 2030
Figure 19. Product Picture of Phenylketonuria
Figure 20. Product Picture of Maple Syrup Urine Disease
Figure 21. Product Picture of Argininosuccinic Acidemia
Figure 22. Product Picture of Citrullinemia
Figure 23. Product Picture of Homocystinuria
Figure 24. Global Amino Acid Metabolism Disorder Drug Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 25. Global Amino Acid Metabolism Disorder Drug Sales Value Market Share by Application, 2023 & 2030
Figure 26. North America Amino Acid Metabolism Disorder Drug Sales Value (2019-2030) & (US$ Million)
Figure 27. North America Amino Acid Metabolism Disorder Drug Sales Value by Country (%), 2023 VS 2030
Figure 28. Europe Amino Acid Metabolism Disorder Drug Sales Value (2019-2030) & (US$ Million)
Figure 29. Europe Amino Acid Metabolism Disorder Drug Sales Value by Country (%), 2023 VS 2030
Figure 30. Asia Pacific Amino Acid Metabolism Disorder Drug Sales Value (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Amino Acid Metabolism Disorder Drug Sales Value by Country (%), 2023 VS 2030
Figure 32. South America Amino Acid Metabolism Disorder Drug Sales Value (2019-2030) & (US$ Million)
Figure 33. South America Amino Acid Metabolism Disorder Drug Sales Value by Country (%), 2023 VS 2030
Figure 34. Middle East & Africa Amino Acid Metabolism Disorder Drug Sales Value (2019-2030) & (US$ Million)
Figure 35. Middle East & Africa Amino Acid Metabolism Disorder Drug Sales Value by Country (%), 2023 VS 2030
Figure 36. Key Countries/Regions Amino Acid Metabolism Disorder Drug Sales Value (%), (2019-2030)
Figure 37. United States Amino Acid Metabolism Disorder Drug Sales Value, (2019-2030) & (US$ Million)
Figure 38. United States Amino Acid Metabolism Disorder Drug Sales Value by Type (%), 2023 VS 2030
Figure 39. United States Amino Acid Metabolism Disorder Drug Sales Value by Application (%), 2023 VS 2030
Figure 40. Europe Amino Acid Metabolism Disorder Drug Sales Value, (2019-2030) & (US$ Million)
Figure 41. Europe Amino Acid Metabolism Disorder Drug Sales Value by Type (%), 2023 VS 2030
Figure 42. Europe Amino Acid Metabolism Disorder Drug Sales Value by Application (%), 2023 VS 2030
Figure 43. China Amino Acid Metabolism Disorder Drug Sales Value, (2019-2030) & (US$ Million)
Figure 44. China Amino Acid Metabolism Disorder Drug Sales Value by Type (%), 2023 VS 2030
Figure 45. China Amino Acid Metabolism Disorder Drug Sales Value by Application (%), 2023 VS 2030
Figure 46. Japan Amino Acid Metabolism Disorder Drug Sales Value, (2019-2030) & (US$ Million)
Figure 47. Japan Amino Acid Metabolism Disorder Drug Sales Value by Type (%), 2023 VS 2030
Figure 48. Japan Amino Acid Metabolism Disorder Drug Sales Value by Application (%), 2023 VS 2030
Figure 49. South Korea Amino Acid Metabolism Disorder Drug Sales Value, (2019-2030) & (US$ Million)
Figure 50. South Korea Amino Acid Metabolism Disorder Drug Sales Value by Type (%), 2023 VS 2030
Figure 51. South Korea Amino Acid Metabolism Disorder Drug Sales Value by Application (%), 2023 VS 2030
Figure 52. Southeast Asia Amino Acid Metabolism Disorder Drug Sales Value, (2019-2030) & (US$ Million)
Figure 53. Southeast Asia Amino Acid Metabolism Disorder Drug Sales Value by Type (%), 2023 VS 2030
Figure 54. Southeast Asia Amino Acid Metabolism Disorder Drug Sales Value by Application (%), 2023 VS 2030
Figure 55. India Amino Acid Metabolism Disorder Drug Sales Value, (2019-2030) & (US$ Million)
Figure 56. India Amino Acid Metabolism Disorder Drug Sales Value by Type (%), 2023 VS 2030
Figure 57. India Amino Acid Metabolism Disorder Drug Sales Value by Application (%), 2023 VS 2030
Figure 58. Amino Acid Metabolism Disorder Drug Industrial Chain
Figure 59. Amino Acid Metabolism Disorder Drug Manufacturing Cost Structure
Figure 60. Channels of Distribution (Direct Sales, and Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
